RINVOQ Complete Rebate Logo

Getting reimbursed

If you're an eligible, commercially insured patient, you may still be able to get RINVOQ for as little as $5 a month* using the RINVOQ Complete Prescription Rebate.

Woman filling up water canteen while having Rheumatoid Arthritis Woman filling up water canteen while having Rheumatoid Arthritis Woman filling up water canteen while having Rheumatoid Arthritis

Here’s How To Do It:

Collect all of your receipts. Wondering what would be accepted as a receipt? Just call us at 1.800.2RINVOQ (1.800.274.6867) for help

Log in or sign up for an account at the CompleteRebate.com savings portal

Upload your receipts

Note: If you are paying for RINVOQ with a Flexible Spending Account (FSA), Health Savings Account (HSA), or Health Reimbursement Account (HRA), or if your insurance provider prohibits participation in the program, your prescription is not eligible for reimbursement.

Rebates are available only to patients with commercial prescription coverage or those who are self-insured.

Eligibility: Available to patients with commercial prescription insurance coverage for RINVOQ (upadacitinib) who meet eligibility criteria. Co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense or Veteran’s Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state or government-funded healthcare program, patient will no longer be able to use the RINVOQ Complete Savings Card and patient must call RINVOQ Complete at 1.800.2RINVOQ (1.800.274.6867) to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the RINVOQ Complete program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance.

 

RINVOQ Complete Savings Card Terms and Conditions

Terms and Conditions apply. This benefit covers RINVOQ™ (upadacitinib) alone or for RINVOQ plus one of the following medications: methotrexate, leflunomide (Arava®), or hydroxychloroquine (Plaquenil®). Eligibility: Available to patients with commercial prescription insurance coverage for RINVOQ who meet eligibility criteria. Co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the RINVOQ Complete Savings Card and patient must call RINVOQ Complete at 1.800.2RINVOQ to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the RINVOQ Complete program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. Patients who are members of insurance plans that claim to reduce or eliminate their patients' out of pocket co-pay, co-insurance, or deductible obligations for certain prescription drugs based upon the availability of, or patient's enrollment in, manufacturer sponsored co-pay assistance for such drugs (often termed "maximizer" programs) will have an annual maximum program benefit of $6,000.00 per calendar year. This assistance offer is not health insurance. To learn about AbbVie’s privacy practices and your privacy choices, visit www.abbvie.com/privacy.html

Arava and Plaquenil are registered trademarks of their respective owners.